Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-label, non-inferiority, randomised controlled trial

The Lancet Child & Adolescent Health · Elsevier

Аннотация

Publication date: November 2026 Source: The Lancet Child & Adolescent Health, Volume 10, Issue 11 Author(s): Daniel J Kapelus, Courtney P Olwagen, Alane Izu, Heena Ranchod, Christian K Mukendi, Eleonora A M L Mutsaerts, Anthonet Koen, Lisa Jose, Gaurav Kwatra, Sian E Faustini, Alex G Richter, Shabir A Madhi

Читать у издателя →

Похожие статьи